Insider Trading History of Shaffer James P

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Shaffer James P since 2012. The trader's CIK number is 1488919. At the time of the last reporting, Shaffer James P was the VP & Chief Commercial Officer of Eiger Biopharmaceuticals, Inc.. (stock ticker symbol EIGR). Also see all insider trading activities at Eiger Biopharmaceuticals, Inc..

Note that in the past Shaffer James P also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Eiger Biopharmaceuticals, Inc. (EIGR) by Shaffer James P

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 EIGR 5,620 $101,435 0 $0 0 $0

Yearly summary of insider trading at Halozyme Therapeutics, Inc. (HALO) by Shaffer James P

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 HALO 0 $0 0 $0 16,493 $0
2013 HALO 0 $0 0 $0 11,232 $0
2012 HALO 20,000 $104,400 0 $0 0 $0


Insider trading activities at 2 companies by Shaffer James P:

1. Eiger Biopharmaceuticals, Inc. (EIGR)

2. Halozyme Therapeutics, Inc. (HALO)

Table 1. Insider trading of Eiger Biopharmaceuticals, Inc. (EIGR) by Shaffer James P

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-08-18 EIGR Buy 3,125 15.70 49,062
2016-06-13 EIGR Buy 1,250 22.18 27,721
2016-05-19 EIGR Buy 500 19.52 9,760
2016-05-23 EIGR Buy 745 19.99 14,892

Table 2. Insider trading of Halozyme Therapeutics, Inc. (HALO) by Shaffer James P

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-02-04 HALO Option Ex 4,864 .00 0
2014-02-02 HALO Option Ex 11,629 .00 0
2013-02-02 HALO Option Ex 11,232 .00 0
2012-11-14 HALO Buy 20,000 5.22 104,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shaffer James P (VP & Chief Commercial Officer of Eiger Biopharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.